reverse transcriptase inhibitors such abacavir, tenofovir and emtricitabine and an integrase transcriptase inhibitor such as efavirenz or boosted protease inhibitor such as darunavir. This therapy should be begin as soon as there is a diagnosis for maximum therapeutic effect (Günthard et al., 2014). The effectiveness of treatment has led to a general acceptance of HIV as a chronic rather than terminal illness (Krummenacher, Cavassini, Bugnon, & Schneider, 2011). The complacency of the public to HIV is in part due to the effectiveness of the antiretroviral therapy. Yet, another causative factor may be the increase in casual sex or the “hook up” culture which is promoted by mobile technology with apps that promote promiscuous and high risk sexual behavior and facilitate these interactions. Studies, in fact, do show an increase in riskier sexual behavior for MSM connected to dating apps (Beymer et. al, 2014). Strategies to Increase Awareness The early years of the HIV/AIDS epidemic saw widespread media coverage and the public was constantly bombarded with the dangers of the disease. Now that the mortatility rates have declined and the media’s spotlight has diminished as a result. Healthcare practitioners must identify at risk individuals and take a patient centered approach that is based on their patient’s risk. Providers who find patients at risk should be willing to prescribe PrEP or antiretroviral pre- exposure prophylaxis which in trials has reduced the rate of HIV transmission in high risk populations by 44% (Krakower & Mayer, 2012). For patients are living with HIV medication adherence becomes top priority. A recent study found that patients receiving an interdisciplinary plan that included electronic monitoring of drug therapy along with motivational interviews was effective in increasing adherence rates (Krummenacher, Cavassini, Bugnon, & Schneider, 2011).
- Fall '13